Use of prednisolone as monotherapy in the treatment of feline pemphigus foliaceus: a retrospective study of 37 cats.

Background: Prednisone doses of up to 8 mg/kg/day have been used to treat feline pemphigus foliaceus (PF). Oral prednisolone has more favourable pharmacokinetics in cats than prednisone; therefore, lower doses of prednisolone may be effective in treating feline PF.

Hypothesis/objectives: To assess the dose of prednisolone required to induce and maintain remission of PF in cats.

Canine pyoderma gangrenosum: a case series of two dogs.

Background: Pyoderma gangrenosum (PG) is a rare disease, which, to the best of the authors' knowledge, has been the subject of only one case report in the peer-reviewed veterinary literature.

Hypothesis/objectives: To describe the history, clinical signs, diagnostic findings and treatment outcome in two cases of canine PG.

Animals: Two client-owned dogs presented to a private veterinary referral practice between 2008 and 2010 who received a diagnosis of PG by specialist veterinary dermatologists.